nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—Pulmonary eosinophilia—Dapsone—leprosy	0.0714	0.0867	CcSEcCtD
Trandolapril—Ichthyosis acquired—Thalidomide—leprosy	0.0579	0.0703	CcSEcCtD
Trandolapril—Ichthyosis—Thalidomide—leprosy	0.0579	0.0703	CcSEcCtD
Trandolapril—Blood creatinine decreased—Thalidomide—leprosy	0.0319	0.0387	CcSEcCtD
Trandolapril—ACE—hindlimb—leprosy	0.03	0.171	CbGeAlD
Trandolapril—ACE—arm—leprosy	0.0286	0.163	CbGeAlD
Trandolapril—ACE—appendage—leprosy	0.0257	0.146	CbGeAlD
Trandolapril—ACE—peripheral nervous system—leprosy	0.0234	0.133	CbGeAlD
Trandolapril—ACE—nerve—leprosy	0.0182	0.104	CbGeAlD
Trandolapril—ACE—blood vessel—leprosy	0.0143	0.0814	CbGeAlD
Trandolapril—Peripheral vascular disorder—Thalidomide—leprosy	0.0136	0.0165	CcSEcCtD
Trandolapril—White blood cell count decreased—Thalidomide—leprosy	0.0134	0.0163	CcSEcCtD
Trandolapril—Transient ischaemic attack—Thalidomide—leprosy	0.0132	0.0161	CcSEcCtD
Trandolapril—Platelet count decreased—Thalidomide—leprosy	0.0112	0.0136	CcSEcCtD
Trandolapril—Psoriasis—Thalidomide—leprosy	0.0106	0.0129	CcSEcCtD
Trandolapril—Hyperlipidaemia—Thalidomide—leprosy	0.00927	0.0112	CcSEcCtD
Trandolapril—Myocardial ischaemia—Thalidomide—leprosy	0.00831	0.0101	CcSEcCtD
Trandolapril—Pancreatitis—Dapsone—leprosy	0.00803	0.00974	CcSEcCtD
Trandolapril—ACE—eye—leprosy	0.00761	0.0433	CbGeAlD
Trandolapril—Jaundice cholestatic—Thalidomide—leprosy	0.0076	0.00922	CcSEcCtD
Trandolapril—Photosensitivity reaction—Dapsone—leprosy	0.00747	0.00906	CcSEcCtD
Trandolapril—Hypocalcaemia—Thalidomide—leprosy	0.0073	0.00885	CcSEcCtD
Trandolapril—Hyperuricaemia—Thalidomide—leprosy	0.0072	0.00873	CcSEcCtD
Trandolapril—Leukocytosis—Thalidomide—leprosy	0.00711	0.00862	CcSEcCtD
Trandolapril—Hypercholesterolaemia—Thalidomide—leprosy	0.00706	0.00857	CcSEcCtD
Trandolapril—Creatinine increased—Thalidomide—leprosy	0.00702	0.00851	CcSEcCtD
Trandolapril—Bone pain—Thalidomide—leprosy	0.00697	0.00846	CcSEcCtD
Trandolapril—Atrioventricular block—Thalidomide—leprosy	0.00689	0.00835	CcSEcCtD
Trandolapril—Blood uric acid increased—Thalidomide—leprosy	0.0068	0.00825	CcSEcCtD
Trandolapril—Hyperkalaemia—Thalidomide—leprosy	0.00656	0.00796	CcSEcCtD
Trandolapril—Pharyngitis—Dapsone—leprosy	0.0065	0.00789	CcSEcCtD
Trandolapril—Blood urea increased—Thalidomide—leprosy	0.00631	0.00765	CcSEcCtD
Trandolapril—CES1—testis—leprosy	0.00627	0.0357	CbGeAlD
Trandolapril—CES1—nervous system—leprosy	0.00616	0.0351	CbGeAlD
Trandolapril—Tinnitus—Dapsone—leprosy	0.00611	0.00741	CcSEcCtD
Trandolapril—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00557	0.00676	CcSEcCtD
Trandolapril—Photosensitivity—Thalidomide—leprosy	0.00552	0.0067	CcSEcCtD
Trandolapril—Eczema—Thalidomide—leprosy	0.00539	0.00654	CcSEcCtD
Trandolapril—Renal failure acute—Thalidomide—leprosy	0.00525	0.00637	CcSEcCtD
Trandolapril—Libido decreased—Thalidomide—leprosy	0.00523	0.00634	CcSEcCtD
Trandolapril—Vertigo—Dapsone—leprosy	0.00512	0.00622	CcSEcCtD
Trandolapril—Visual disturbance—Thalidomide—leprosy	0.00512	0.00621	CcSEcCtD
Trandolapril—Arthritis—Thalidomide—leprosy	0.00499	0.00605	CcSEcCtD
Trandolapril—Cough—Dapsone—leprosy	0.00498	0.00604	CcSEcCtD
Trandolapril—Cardiac failure—Thalidomide—leprosy	0.00497	0.00603	CcSEcCtD
Trandolapril—Cerebrovascular accident—Thalidomide—leprosy	0.00495	0.006	CcSEcCtD
Trandolapril—Hyponatraemia—Thalidomide—leprosy	0.00487	0.00591	CcSEcCtD
Trandolapril—Osteoarthritis—Thalidomide—leprosy	0.00485	0.00588	CcSEcCtD
Trandolapril—Pain in extremity—Thalidomide—leprosy	0.00485	0.00588	CcSEcCtD
Trandolapril—Disturbance in sexual arousal—Thalidomide—leprosy	0.00481	0.00584	CcSEcCtD
Trandolapril—Migraine—Thalidomide—leprosy	0.00477	0.00579	CcSEcCtD
Trandolapril—Cardiac arrest—Thalidomide—leprosy	0.00461	0.00559	CcSEcCtD
Trandolapril—Tachycardia—Dapsone—leprosy	0.00454	0.00551	CcSEcCtD
Trandolapril—Blood creatinine increased—Thalidomide—leprosy	0.00454	0.00551	CcSEcCtD
Trandolapril—Liver function test abnormal—Thalidomide—leprosy	0.00448	0.00543	CcSEcCtD
Trandolapril—Dry skin—Thalidomide—leprosy	0.00444	0.00539	CcSEcCtD
Trandolapril—Breast disorder—Thalidomide—leprosy	0.00438	0.00531	CcSEcCtD
Trandolapril—Cramp muscle—Thalidomide—leprosy	0.00437	0.0053	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00437	0.0053	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Thalidomide—leprosy	0.00428	0.00519	CcSEcCtD
Trandolapril—Abdominal distension—Thalidomide—leprosy	0.00422	0.00512	CcSEcCtD
Trandolapril—Insomnia—Dapsone—leprosy	0.00421	0.00511	CcSEcCtD
Trandolapril—ACE—testis—leprosy	0.00417	0.0238	CbGeAlD
Trandolapril—Eosinophilia—Thalidomide—leprosy	0.00415	0.00503	CcSEcCtD
Trandolapril—Pancreatitis—Thalidomide—leprosy	0.00411	0.00498	CcSEcCtD
Trandolapril—ACE—nervous system—leprosy	0.0041	0.0233	CbGeAlD
Trandolapril—Angina pectoris—Thalidomide—leprosy	0.00408	0.00495	CcSEcCtD
Trandolapril—Bronchitis—Thalidomide—leprosy	0.00403	0.00489	CcSEcCtD
Trandolapril—Pancytopenia—Thalidomide—leprosy	0.00398	0.00483	CcSEcCtD
Trandolapril—Neutropenia—Thalidomide—leprosy	0.00392	0.00475	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Thalidomide—leprosy	0.00389	0.00472	CcSEcCtD
Trandolapril—Pollakiuria—Thalidomide—leprosy	0.00387	0.0047	CcSEcCtD
Trandolapril—Erectile dysfunction—Thalidomide—leprosy	0.00386	0.00468	CcSEcCtD
Trandolapril—Photosensitivity reaction—Thalidomide—leprosy	0.00382	0.00464	CcSEcCtD
Trandolapril—Gastrointestinal pain—Dapsone—leprosy	0.00381	0.00462	CcSEcCtD
Trandolapril—Hyperglycaemia—Thalidomide—leprosy	0.00378	0.00459	CcSEcCtD
Trandolapril—Infestation NOS—Thalidomide—leprosy	0.00374	0.00453	CcSEcCtD
Trandolapril—Infestation—Thalidomide—leprosy	0.00374	0.00453	CcSEcCtD
Trandolapril—Drowsiness—Thalidomide—leprosy	0.00374	0.00453	CcSEcCtD
Trandolapril—Depression—Thalidomide—leprosy	0.00373	0.00452	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Thalidomide—leprosy	0.0037	0.00449	CcSEcCtD
Trandolapril—Acute coronary syndrome—Thalidomide—leprosy	0.00368	0.00447	CcSEcCtD
Trandolapril—Abdominal pain—Dapsone—leprosy	0.00368	0.00446	CcSEcCtD
Trandolapril—Body temperature increased—Dapsone—leprosy	0.00368	0.00446	CcSEcCtD
Trandolapril—Renal failure—Thalidomide—leprosy	0.00367	0.00446	CcSEcCtD
Trandolapril—Myocardial infarction—Thalidomide—leprosy	0.00366	0.00444	CcSEcCtD
Trandolapril—SLC15A2—testis—leprosy	0.00364	0.0207	CbGeAlD
Trandolapril—Sweating—Thalidomide—leprosy	0.00358	0.00435	CcSEcCtD
Trandolapril—SLC15A2—nervous system—leprosy	0.00357	0.0203	CbGeAlD
Trandolapril—Epistaxis—Thalidomide—leprosy	0.00352	0.00428	CcSEcCtD
Trandolapril—Agranulocytosis—Thalidomide—leprosy	0.00349	0.00423	CcSEcCtD
Trandolapril—Bradycardia—Thalidomide—leprosy	0.00341	0.00414	CcSEcCtD
Trandolapril—Rhinitis—Thalidomide—leprosy	0.00336	0.00408	CcSEcCtD
Trandolapril—Hepatitis—Thalidomide—leprosy	0.00335	0.00407	CcSEcCtD
Trandolapril—Pharyngitis—Thalidomide—leprosy	0.00333	0.00404	CcSEcCtD
Trandolapril—Urinary tract disorder—Thalidomide—leprosy	0.00331	0.00402	CcSEcCtD
Trandolapril—Oedema peripheral—Thalidomide—leprosy	0.0033	0.00401	CcSEcCtD
Trandolapril—Urethral disorder—Thalidomide—leprosy	0.00329	0.00399	CcSEcCtD
Trandolapril—Visual impairment—Thalidomide—leprosy	0.00323	0.00392	CcSEcCtD
Trandolapril—Erythema multiforme—Thalidomide—leprosy	0.00317	0.00385	CcSEcCtD
Trandolapril—Eye disorder—Thalidomide—leprosy	0.00313	0.0038	CcSEcCtD
Trandolapril—Tinnitus—Thalidomide—leprosy	0.00313	0.00379	CcSEcCtD
Trandolapril—Cardiac disorder—Thalidomide—leprosy	0.00311	0.00378	CcSEcCtD
Trandolapril—Angiopathy—Thalidomide—leprosy	0.00304	0.00369	CcSEcCtD
Trandolapril—Immune system disorder—Thalidomide—leprosy	0.00303	0.00368	CcSEcCtD
Trandolapril—Mediastinal disorder—Thalidomide—leprosy	0.00302	0.00367	CcSEcCtD
Trandolapril—Arrhythmia—Thalidomide—leprosy	0.003	0.00363	CcSEcCtD
Trandolapril—Alopecia—Thalidomide—leprosy	0.00296	0.0036	CcSEcCtD
Trandolapril—Vomiting—Dapsone—leprosy	0.00296	0.00359	CcSEcCtD
Trandolapril—Mental disorder—Thalidomide—leprosy	0.00294	0.00356	CcSEcCtD
Trandolapril—Malnutrition—Thalidomide—leprosy	0.00292	0.00354	CcSEcCtD
Trandolapril—Headache—Dapsone—leprosy	0.00292	0.00354	CcSEcCtD
Trandolapril—Flatulence—Thalidomide—leprosy	0.00288	0.00349	CcSEcCtD
Trandolapril—Dysgeusia—Thalidomide—leprosy	0.00286	0.00347	CcSEcCtD
Trandolapril—Back pain—Thalidomide—leprosy	0.00282	0.00343	CcSEcCtD
Trandolapril—Muscle spasms—Thalidomide—leprosy	0.00281	0.00341	CcSEcCtD
Trandolapril—Nausea—Dapsone—leprosy	0.00276	0.00335	CcSEcCtD
Trandolapril—Ill-defined disorder—Thalidomide—leprosy	0.00271	0.00329	CcSEcCtD
Trandolapril—Anaemia—Thalidomide—leprosy	0.0027	0.00327	CcSEcCtD
Trandolapril—Agitation—Thalidomide—leprosy	0.00268	0.00326	CcSEcCtD
Trandolapril—Angioedema—Thalidomide—leprosy	0.00267	0.00324	CcSEcCtD
Trandolapril—Malaise—Thalidomide—leprosy	0.00263	0.00319	CcSEcCtD
Trandolapril—Vertigo—Thalidomide—leprosy	0.00262	0.00318	CcSEcCtD
Trandolapril—Syncope—Thalidomide—leprosy	0.00262	0.00318	CcSEcCtD
Trandolapril—Leukopenia—Thalidomide—leprosy	0.00261	0.00317	CcSEcCtD
Trandolapril—Palpitations—Thalidomide—leprosy	0.00258	0.00313	CcSEcCtD
Trandolapril—Loss of consciousness—Thalidomide—leprosy	0.00257	0.00311	CcSEcCtD
Trandolapril—Cough—Thalidomide—leprosy	0.00255	0.00309	CcSEcCtD
Trandolapril—Chest pain—Thalidomide—leprosy	0.00249	0.00302	CcSEcCtD
Trandolapril—Arthralgia—Thalidomide—leprosy	0.00249	0.00302	CcSEcCtD
Trandolapril—Myalgia—Thalidomide—leprosy	0.00249	0.00302	CcSEcCtD
Trandolapril—Anxiety—Thalidomide—leprosy	0.00248	0.00301	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00247	0.00299	CcSEcCtD
Trandolapril—Discomfort—Thalidomide—leprosy	0.00246	0.00298	CcSEcCtD
Trandolapril—Dry mouth—Thalidomide—leprosy	0.00243	0.00295	CcSEcCtD
Trandolapril—Oedema—Thalidomide—leprosy	0.00238	0.00289	CcSEcCtD
Trandolapril—Infection—Thalidomide—leprosy	0.00237	0.00287	CcSEcCtD
Trandolapril—Shock—Thalidomide—leprosy	0.00234	0.00284	CcSEcCtD
Trandolapril—Nervous system disorder—Thalidomide—leprosy	0.00234	0.00283	CcSEcCtD
Trandolapril—Thrombocytopenia—Thalidomide—leprosy	0.00233	0.00283	CcSEcCtD
Trandolapril—Tachycardia—Thalidomide—leprosy	0.00233	0.00282	CcSEcCtD
Trandolapril—Skin disorder—Thalidomide—leprosy	0.00231	0.00281	CcSEcCtD
Trandolapril—Hyperhidrosis—Thalidomide—leprosy	0.0023	0.00279	CcSEcCtD
Trandolapril—Anorexia—Thalidomide—leprosy	0.00227	0.00276	CcSEcCtD
Trandolapril—Hypotension—Thalidomide—leprosy	0.00223	0.0027	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Thalidomide—leprosy	0.00217	0.00263	CcSEcCtD
Trandolapril—Insomnia—Thalidomide—leprosy	0.00216	0.00261	CcSEcCtD
Trandolapril—Paraesthesia—Thalidomide—leprosy	0.00214	0.0026	CcSEcCtD
Trandolapril—Dyspnoea—Thalidomide—leprosy	0.00212	0.00258	CcSEcCtD
Trandolapril—Somnolence—Thalidomide—leprosy	0.00212	0.00257	CcSEcCtD
Trandolapril—Dyspepsia—Thalidomide—leprosy	0.0021	0.00254	CcSEcCtD
Trandolapril—Decreased appetite—Thalidomide—leprosy	0.00207	0.00251	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Thalidomide—leprosy	0.00206	0.0025	CcSEcCtD
Trandolapril—Fatigue—Thalidomide—leprosy	0.00205	0.00249	CcSEcCtD
Trandolapril—Constipation—Thalidomide—leprosy	0.00204	0.00247	CcSEcCtD
Trandolapril—Feeling abnormal—Thalidomide—leprosy	0.00196	0.00238	CcSEcCtD
Trandolapril—Gastrointestinal pain—Thalidomide—leprosy	0.00195	0.00236	CcSEcCtD
Trandolapril—Urticaria—Thalidomide—leprosy	0.00189	0.0023	CcSEcCtD
Trandolapril—Abdominal pain—Thalidomide—leprosy	0.00188	0.00229	CcSEcCtD
Trandolapril—Body temperature increased—Thalidomide—leprosy	0.00188	0.00229	CcSEcCtD
Trandolapril—Hypersensitivity—Thalidomide—leprosy	0.00176	0.00213	CcSEcCtD
Trandolapril—Asthenia—Thalidomide—leprosy	0.00171	0.00207	CcSEcCtD
Trandolapril—Pruritus—Thalidomide—leprosy	0.00169	0.00205	CcSEcCtD
Trandolapril—Diarrhoea—Thalidomide—leprosy	0.00163	0.00198	CcSEcCtD
Trandolapril—Dizziness—Thalidomide—leprosy	0.00158	0.00191	CcSEcCtD
Trandolapril—Vomiting—Thalidomide—leprosy	0.00152	0.00184	CcSEcCtD
Trandolapril—Rash—Thalidomide—leprosy	0.0015	0.00182	CcSEcCtD
Trandolapril—Dermatitis—Thalidomide—leprosy	0.0015	0.00182	CcSEcCtD
Trandolapril—Headache—Thalidomide—leprosy	0.00149	0.00181	CcSEcCtD
Trandolapril—Nausea—Thalidomide—leprosy	0.00142	0.00172	CcSEcCtD
